Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.07 $5.36 Friday, 10th May 2024 PYXS stock ended at $4.34. This is 3.77% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.57% from a day low at $4.31 to a day high of $4.55.
90 days $3.60 $6.85
52 weeks $1.35 $6.85

Historical Pyxis Oncology, Inc. prices

Date Open High Low Close Volume
May 10, 2024 $4.48 $4.55 $4.31 $4.34 228 969
May 09, 2024 $4.26 $4.55 $4.21 $4.51 426 755
May 08, 2024 $4.38 $4.39 $4.18 $4.27 435 389
May 07, 2024 $4.31 $4.54 $4.26 $4.38 694 066
May 06, 2024 $4.64 $4.64 $4.26 $4.31 349 809
May 03, 2024 $4.50 $4.78 $4.29 $4.38 818 185
May 02, 2024 $4.48 $4.48 $4.31 $4.41 188 791
May 01, 2024 $4.44 $4.70 $4.24 $4.40 642 864
Apr 30, 2024 $4.40 $4.46 $4.38 $4.45 123 786
Apr 29, 2024 $4.37 $4.63 $4.32 $4.44 477 455
Apr 26, 2024 $4.27 $4.42 $4.25 $4.30 163 268
Apr 25, 2024 $4.36 $4.54 $4.26 $4.30 520 139
Apr 24, 2024 $4.51 $4.63 $4.38 $4.45 233 369
Apr 23, 2024 $4.55 $4.72 $4.44 $4.50 383 845
Apr 22, 2024 $4.22 $4.69 $4.16 $4.53 469 827
Apr 19, 2024 $4.46 $4.53 $4.07 $4.16 664 618
Apr 18, 2024 $4.86 $4.86 $4.28 $4.53 467 565
Apr 17, 2024 $4.74 $5.08 $4.74 $4.83 572 584
Apr 16, 2024 $4.63 $5.01 $4.59 $4.69 263 465
Apr 15, 2024 $4.92 $4.98 $4.64 $4.74 434 102
Apr 12, 2024 $5.29 $5.29 $4.88 $4.92 337 577
Apr 11, 2024 $5.16 $5.36 $4.92 $5.27 474 838
Apr 10, 2024 $5.25 $5.29 $4.96 $5.08 664 436
Apr 09, 2024 $5.53 $5.68 $5.28 $5.35 502 833
Apr 08, 2024 $5.49 $5.74 $5.14 $5.58 566 443
Click to get the best stock tips daily for free!

About Pyxis Oncology, Inc.

Pyxis Oncology. Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therap... PYXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT